Shahnam is a registered patent attorney who advises global pharmaceutical, agricultural, and other life science and technology companies on all aspects of patent portfolio development, analysis and appeals, as well as post-grant proceedings and intellectual property transactional activities. He has prepared and prosecuted more than 1,000 U.S. and international patent applications and, as a former patent examiner, provides customized approaches to his clients in a wide range of technologies, including chemistry, pharmaceuticals, pharmacology, biotechnology, medical diagnostics and cosmetic products.

He provides a full range of patent law services to clients, including infringement and validity studies, freedom-to-practice studies and design-around to help clients achieve their strategic and commercial goals. He has also appeared before the Patent Trial and Appeal Board in a number of proceedings on behalf of his clients.

As a Regulatory Affairs Certified (RAC) professional, Shahnam utilizes a strong understanding of the regulatory framework of cannabis and hemp-derived CBD products to advise clients on FDA regulatory matters, marketing and advertising strategies for drug and dietary supplement products.

Before Fox Rothschild

Shahnam was a Patent Examiner with the U.S. Patent and Trademark Office, where he managed an extensive portfolio including pharmaceutical and diagnostic compounds and compositions. He evaluated U.S. and international patent applications for novelty, obviousness, enablement, written description and definiteness.

Prior to entering the legal field, Shahnam was a research associate with Kendle International, where he monitored FDA-required regulatory and clinical data during the Celecoxib clinical trials.

Beyond Fox Rothschild

Shahnam is a licensed pharmacist in Maryland.

Honors & Awards

  • Selected to the "Super Lawyers - Rising Stars" list for Intellectual Property Law in New Jersey (2013)*

*Awards Methodology